Clinical trial
Pentoxifylline in the Treatment of NEC in Premature Neonates
NCT00271336 · Shaare Zedek Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00271336 |
|---|---|
| Title | Pentoxifylline in the Treatment of NEC in Premature Neonates |
| Official title | Pentoxifylline in the Treatment of Necrotizing Enterocolitis in Premature Neonates |
| Lead sponsor | Shaare Zedek Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Necrotizing Enterocolitis |
| Intervention type | Drug |
| Interventions | Pentoxifylline |
| Enrollment | 50 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Dec 30, 2005 |
| Last update posted | May 23, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: